Caspase 9 (Casp9) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Caspase 9 (CASP9) is an initiator caspase that plays a central role in the intrinsic (mitochondrial-mediated) apoptotic pathway. It is encoded by the CASP9 gene located on chromosome 1p12-p11 and is activated in response to mitochondrial outer membrane permeabilization (MOMP).
| Caspase 9 | |
|---|---|
| Gene Symbol | CASP9 |
| Full Name | Caspase 9 |
| Chromosome | 1p12-p11 |
| NCBI Gene ID | 842 |
| OMIM | 602234 |
| Ensembl ID | ENSG00000132906 |
| UniProt ID | P55211 |
Caspase-9 exists as an inactive zymogen (procaspase-9) in the mitochondrial intermembrane space and cytoplasm. Upon apoptotic stimuli that cause mitochondrial outer membrane permeabilization (MOMP), cytochrome c is released into the cytoplasm[1].
Cytochrome c binds to Apaf-1 (Apoptotic protease activating factor 1), which together with dATP/ATP forms the apoptosome. Procaspase-9 is recruited to the apoptosome, where it undergoes activation through dimerization[2].
Active caspase-9 then cleaves and activates downstream executioner caspases (caspase-3, -6, -7), leading to apoptosis. The activity of caspase-9 is regulated by:
In Alzheimer's disease, mitochondrial dysfunction leads to increased MOMP and caspase-9 activation:
Caspase-9 mediates dopaminergic neuron death through:
In amyotrophic lateral sclerosis:
Caspase-9 inhibitors are being explored for neuroprotection:
| Agent | Mechanism | Status | Disease |
|---|---|---|---|
| Z-LEHD-FMK | Caspase-9 inhibitor | Preclinical | Stroke, AD |
| Ac-LEHD-CHO | Reversible inhibitor | Research | Neuroprotection |
| XIAP antagonists | Release caspase-9 | Research | Cancer, neurodegeneration |
| Disease | Role | Evidence |
|---|---|---|
| Alzheimer's Disease | Mitochondrial apoptosis | Elevated caspase-9 in AD brain[3] |
| Parkinson's Disease | Dopaminergic neuron death | Activated in PD models[4] |
| ALS | Motor neuron death | Caspase-9 in ALS spinal cord |
| Stroke | Ischemic injury | Mediates neuronal death post-stroke |
CASP9 is expressed in multiple brain regions:
[1] Li P, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997.
[2] Rodriguez J, Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 1999.
[3] Harwood SM, et al. Caspase-9 is the principal caspase responsible for the cleavage of the human Alzheimer-associated tau protein. J Alzheimers Dis. 2005.
[4] Wang H, et al. The role of mitochondrial pathways in the pathogenesis of Parkinson's disease. J Neural Transm (Vienna). 2018.
The study of Caspase 9 (Casp9) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Li P, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91(4):479-489.
[2] Rodriguez J, Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 1999;13(24):3179-3184.
[3] Harwood SM, et al. Caspase-9 is the principal caspase responsible for the cleavage of the human Alzheimer-associated tau protein. J Alzheimers Dis. 2005;7(4):243-254.
[4] Wang H, et al. The role of mitochondrial pathways in the pathogenesis of Parkinson's disease. J Neural Transm (Vienna). 2018;125(3):349-367.